Source: 2021 Mako Capital Deck and The clinical and economic value of Mako SmartRobotics

Stryker enabling surgeons to have a more predictable surgical experience with the launch of Mako SmartRobotics™ in Brazil. 


The first and only robotic technology that can be used across the joint replacement service line to perform total knee, total hip and partial knee replacements now available

Sao Paolo, Brazil – July, 2021 - Stryker announced the commercial launch of Mako SmartRobotics™ for the Brazilian market. The Mako System is the first and only robotic technology that can be used across the joint replacement service line to perform total knee, total hip and partial knee replacements.

Mako SmartRobotics ™ combines three key components—3D CT-based planning, AccuStop™ haptic technology and insightful data analytics—into one platform. This has shown to deliver better outcomes to total hip, total knee and partial knee patients. 1

Through CT-based 3D modeling of bone anatomy, surgeons can use the Mako System to create a personalized surgical plan and identify the implant size, orientation and alignment based on each patient's unique anatomy. The Mako System also enables surgeons to virtually modify the surgical plan intra-operatively and assists the surgeon in executing bone resections, with the exclusive safety offered by the Accustop™ haptic technology, which prevents the surgeon from making unplanned cutting or milling movements.

Broad research on Mako has shown “potential clinical, functional and economic value of the Mako system and the corresponding partial knee, total knee and total hip implant systems.” In addition, it has demonstrated the improvement on patients’ outcomes, reduction in using health resources and cost savings.2

Total knee and total hip replacements in the United States are expected to increase 85 percent and 71 percent, respectively by 20302. As this procedural growth materializes, surgeons will continue to seek clinical solutions that leverage technological advancements to improve their patient's satisfaction.

"We are excited to be leading the transformation of the orthopedics industry with the commercial launch of the Mako System," said Fernando Guerra, General Manager of Stryker’s Brazil business. "We believe that pairing our Mako robotic-arm technology with our market leading implant systems will enable surgeons to have an improved surgical experience."

More than 500,000 Mako procedures, including total knee, partial knee and total hip replacements, have been performed until today. More than 1,000 Mako Systems have been placed in 29 countries.2

To know more about the Mako System, please visit https://www.stryker.com/us/en/portfolios/orthopaedics/joint-replacement/mako-robotic-arm-assisted-surgery.html

About Stryker
Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at stryker.com.

Laura Hungria
Stryker Latin America
55 11 94222 7752

  1. Illgen RL, Bukowski BR, Abiola R, et al. Robotic-assisted total hip arthroplasty: outcomes at minimum two year follow up. Surg Technol Int. 2017;30:365-372.

    Kayani B, Konan S, Tahmassebi J, Pietrzak JRT, Haddad FS. Robotic-arm assisted total knee arthroplasty is associated with improved early functional recovery and reduced time to hospital discharge compared with conventional jig-based total knee arthroplasty: a prospective cohort study. Bone Joint J. 2018;100-B(7):930-937. doi:10.1302/0301-620X.100B7.BJJ-2017-1449.R1

    Kleeblad LJ, Borus T, Coon TM, Dounchis J, Nguyen JT, Pearle AD. Midterm survivorship and patient satisfaction of robotic-arm-assisted medial unicompartmental knee arthroplasty: a multicenter study. J Arthroplasty.
    2018;33(6):1719-1726. doi:10.1016/j.arth.2018.01.036

  2. The Clinical and Economic Value of Mako SmartRobotics™. 2020